![]() 230000000415 inactivating Effects 0.000 claims description 2.239000012141 concentrate Substances 0.000 claims description 5.108010064785 Phospholipases Proteins 0.000 claims description 11.102000015439 Phospholipases Human genes 0.000 claims description 11.238000004519 manufacturing process Methods 0.000 claims description 12.238000006460 hydrolysis reaction Methods 0.000 claims description 13. ![]() 238000004945 emulsification Methods 0.000 claims description 13.238000000265 homogenisation Methods 0.000 claims description 18.125000000899 L-alpha-glutamyl group Chemical group 0.000 claims description 19.238000002360 preparation method Methods 0.000 claims description 32.239000000203 mixture Substances 0.000 claims abstract description 43.235000013365 dairy product Nutrition 0.000 claims abstract description 52.239000006071 cream Substances 0.000 claims abstract description 59.239000000839 emulsion Substances 0.000 title abstract description 21.108010046377 Whey Proteins Proteins 0.000 title claims abstract description 78.102000007544 Whey Proteins Human genes 0.000 title claims abstract description 78.235000021119 whey protein Nutrition 0.000 title claims abstract description 113.filed Critical Novozymes North America, Inc. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US63645300A external-priority Application filed by Novozymes North America, Inc. Priority date (The priority date is an assumption and is not a legal conclusion. Inventor Chris Pernell Original Assignee Novozymes North America, Inc.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |